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To everyone who has experienced or will experience depression,  
and to everyone who knows them. 
 
 
 
 
 
“There is no need for temples. 
Our own brain, our own heart is our temple; the philosophy is kindness.”  
Dalai Lama XIV 
  
  
  
ABSTRACT 
This thesis investigated factors contributing to the high variability of observed cognitive 
deficits (Studies I, II, III), and reversibility of cognitive deficits (Studies III, IV), in old-age 
depression. Dementia-free nondepressed and depressed (unipolar; ICD-10 criteria) 
participants from the population-based Swedish National study on Aging and Care-
Kungsholmen (SNAC-K) who underwent extensive neuropsychological testing formed the 
basis of the study samples.  
Study I assessed the influence of depression severity on cognitive performance, while 
controlling for a range of clinical and demographic factors. Individuals with moderate/severe 
depression exhibited deficits in multiple cognitive domains, whereas only processing speed 
was affected in mild depression. Study II examined the influence of combined KIBRA (CC) 
and CLSTN2 (TT) risk alleles on episodic memory performance. Episodic memory deficits 
were only observed in individuals with both depression and the disadvantageous CC/TT 
allelic combination. Study III investigated the role of psychiatric history on cognitive 
performance in acute and remitted states of depression. Currently depressed individuals with 
a psychiatric inpatient history and individuals with late-onset depression performed at the 
lowest levels, whereas cognitive performance in individuals with self-reported recurrent 
unipolar depression was intermediate. Individuals with remitted unipolar depression exhibited 
no cognitive deficits. Physical inactivity, cumulative inpatient days, heart disease burden, and 
prodromal dementia modulated cognitive performance. Study IV assessed cognitive 
performance in different depression courses (depressed-remitted, remitted-depressed, and 
nondepressed-late-onset depression) longitudinally over a maximum period of 6 years. 
Cognitive decline was observed in all groups for multiple domains, although individuals who 
changed their status from nondepressed to depressed showed exacerbated cognitive decline. 
In remitted states, only processing speed and attention were affected. However, these deficits 
were modulated by benzodiazepine intake. 
In sum, depression-related cognitive deficits were observed in processing speed, attention, 
executive function, verbal fluency (Studies I, III, IV), episodic memory (Studies I, II), and 
semantic memory (Study I). No depression-related deficits were observed in general 
knowledge, short-term memory, or spatial ability. As multiple factors were found to modulate 
cognitive performance in dementia-free unipolar old-age depression, and consistent with the 
notion that depression is a heterogeneous disorder, this may explain why patterns of cognitive 
deficits in depression vary between studies. Recurrence rates of depression remain high, and 
cognitive deficits in depression are associated with a poor prognosis and take a longer time to 
recover than depressive symptoms. This underscores the importance of early detection of 
cognitive deterioration in depression. Importantly, cognitive deficits in depression seem 
largely reversible. Thus, they should be regarded as treatment targets rather than as stable 
vulnerabilities. Combined profiles of psychiatric history, cognitive performance, and health 
behaviors may provide important information to individualized treatment. 
SAMMANFATTNING 
Denna avhandling undersökte faktorer som kunnat bidra till den stora variation som 
observerats i studier rörande kognitiva nedsättningar hos äldre deprimerade (Studie I, II, III), 
och deras reversibilitet (Studie III, IV). Icke-deprimerade personer och deprimerade personer 
(unipolär depression; ICD-10 kriterier) utan demens som deltagit i den populationsbaserade 
SNAC-K studien och genomgått kognitiv testning, utgjorde grunden för studiernas 
undersökningsgrupper.  
Studie I undersökte påverkan av depressionsgrad på kognitiv prestation, när man kontrollerar 
för kliniska och demografiska faktorer. Personer med måttlig/svår depression uppvisade 
nedsättningar i flera kognitiva domäner, däremot var endast mental hastighet nedsatt hos 
personer med mild depression. Studie II undersökte påverkan av kombinationen av KIBRA 
(CC) och CLSTN2 (TT) risk-alleler på prestation i episodiskt minne. Nedsättning i episodiskt 
minne observerades enbart för personer med både depression och de två risk- allelerna 
(CC/TT). Studie III undersökte påverkan av psykiatrisk historik på kognitiv prestation hos 
personer som antingen var i en depressiv episod eller återhämtat sig därifrån. Deprimerade 
personer med psykiatrisk historik, och personer med depressions-debut vid högre ålder 
presterade sämst kognitivt. Personer med självrapporterad historik av återkommande 
depressiva episoder presterade på en mellannivå, medan personer som återhämtat sig inte 
uppvisade några kognitiva nedsättningar. Fysisk inaktivitet, kumulativa sjukhusvistelser, 
hjärtsjukdom och preklinisk demens modulerade gruppskillnader i kognitiva förmågor. 
Studie IV undersökte kognitiv prestation longitudinellt under olika depressions-faser 
(deprimerad - återhämtad, återhämtad - deprimerad, icke-deprimerad - depressions debut). 
Kognitivt åldrande observerades för samtliga grupper i flera kognitiva domäner, däremot 
försämrades personer som utvecklade depression vid uppföljningen i snabbare takt. Vid 
återhämtning från depression observerades enbart nedsatt prestation i mental hastighet och 
uppmärksamhet, men dessa nedsättningar kunde delvis förklaras av intag av benzodiazepiner.  
Sammantaget observerades depressionsrelaterade kognitiva nedsättningar i mental hastighet, 
uppmärksamhet, exekutiva funktioner, verbalt flöde (Studie I, III, IV), episodiskt minne 
(Studie I, II) och semantiskt minne (ordkunskap; Studie I). Inga kognitiva nedsättningar 
observerades i kunskapsminne, korttidsminne eller spatial förmåga. Då en rad faktorer 
modulerade kognitiv prestation hos personer med unipolär depression utan demens, och 
depression är ett heterogent syndrom, kan detta förklara varför mönster av kognitiva 
nedsättningar skiljer sig mellan studier. Depressionsåterfall är mycket vanligt, och kognitiva 
nedsättningar i depression är kopplade till en dyster prognos, och kan ta längre tid att 
återhämta sig från relativt depressiva symptom. Därför är det av stor vikt att upptäcka 
depression i ett tidigt skede. Kognitiva nedsättningar i depression verkar i stor utsträckning 
vara reversibla. De bör därför betraktas som behandlingsbara tillstånd istället för stabila 
nedsättningar. Kombinerade profiler av psykiatrisk historik, kognitiv prestation och 
hälsobeteenden kan ge viktig information till en mer individualiserad behandling.   
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1 INTRODUCTION  
1.1 DEPRESSION 
Depression has been documented throughout history. In Ancient Greece, disease was thought to 
result from imbalances of the four bodily fluids (blood, yellow bile, black bile, and phlegm). 
Hippocrates (460-377 BC) described melancholia, which included a broad spectrum of 
conditions, as a distinct disease caused by excess of black bile from the spleen that affected the 
brain (Davison, 2006).  
Today, there are two major diagnostic manuals of mental disorders: the American Diagnostical 
and Statistical Manual for Mental Disorders (DSM-5; APA, 2013) and the European 
International Classification of Mental and Behavioural Disorders (ICD-10; WHO, 1993). 
However, it was not until 1952 (DSM-I; APA) that the first diagnostic criteria for mental 
disorders emerged (ICD-8 came in the early 60’s). Since then, depression has had several 
categorizations, including neurosis (DSM-II; APA, 1968) and affective psychosis (ICD-8; 
WHO, 1965). The variability in conceptualization and diagnostic criteria for depression 
suggests difficulties in conceptualizing emotional disorders. Today, depression is categorized as 
affective disorders by ICD-10 (WHO, 1993) and as depressive disorders by DSM-5 (APA, 
2013), and consists of multiple types (e.g., unipolar, bipolar, cyclothymia, dysthymia) and 
specifiers (e.g., mild, moderate, severe, with or without psychotic symptoms). 
Unipolar depression (in contrast to bipolar disorders, with occurrence of both depressive and 
manic episodes) is primarily characterized by low mood, loss of interest and enjoyment (also 
called anhedonia), and reduced energy leading to diminished activity. The depressive symptoms 
should represent a change from previous functioning, and should last at least 2 weeks. 
According to ICD-10 criteria, at least two of the above mentioned symptoms, plus at least two 
of the following symptoms should be present to diagnose mild depression (4 depressive 
symptoms): reduced concentration and attention; reduced self-esteem and self-confidence; ideas 
of guilt and unworthiness; bleak and pessimistic views of the future; ideas or acts of self-harm 
or suicide; disturbed sleep, and; disturbed appetite. As depressed individuals may exhibit a wide 
variation in symptoms, depression is considered a heterogeneous disorder (Fava & Kendler, 
2000).  
Depression is a leading cause of global disease burden (Ferrari et al., 2013), accompanied by 
emotional and functional disability (APA, 2013), and affects more than 350 million people 
globally across all ages (WHO, 2005). Depression is not only highly prevalent, but also highly 
recurrent; the life time risk of depression is higher for women (10-25%) than men (5-12%), and 
the majority (25-75%) have more than one episode (APA, 2000). Furthermore, rates of 
recurrence tends to increase with subsequent episodes (APA, 2000), and comorbidity occurs 
frequently, such as anxiety disorders (Moffitt et al., 2007). The median age of onset for 
depression is 32 years, and about 10% have their first depressive episode after the age of 55 
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(APA, 2000). Depression is also related to suicide; about 15% of clinically depressed 
individuals take their lives (Yen et al., 2003). Thus, for the majority of people with depressive 
disorders the prognosis is a life-long disorder with multiple recurrences (WHO, 1993; 2005; 
APA, 2000).  
A negative view of the world, oneself, and the future is characteristic of depression (Beck, 
1967). This “negative cognitive triad” is related to biases in attention and memory, such that 
negative information is more easily attended to and recalled (Matthews & MacLeod, 2005). 
Furthermore, rumination (recycling of negative thoughts) is frequently occurring in depression 
(Aldao et al., 2010), and prolongs negative mood (Cooney et al., 2010; Scheppes, et al., 2015). 
Thus, emotion regulation is affected in depression (Sheppes et al., 2015), which in turn affects 
inhibitory cognitive control (Joorman & Gotlib, 2010; Zetsche et al., 2012). 
The etiology of depression is recognized as a complex interplay between nature and nurture 
(Colman et al., 2014; Pasquini et al., 2014). Thus, biological vulnerabilities are thought to 
interact with environmental risk factors. There are numerous risk-factors and endophenotypes 
for depression (see Goldstein & Klein, 2014, for a review), where at least some of the 
associations appear to be causal: female gender, stressful life events, adverse childhood 
experiences, and the personality trait neuroticism (Fava & Kendler, 2000). There is an increased 
risk of depression in first-degree relatives (30-40%; Kendler et al., 2006; Sullivan et al., 2000). 
However, it seems that the risk for depression arises from multiple susceptibility genes, each of 
which has a small effect that is neither necessary nor sufficient for development of depression 
(Lau & Elay, 2010). Stress may be defined as when a person perceives that demands or threats 
to their well-being are higher than the available resources (Lazarus, 1999). Early exposure to 
adversive stress (prenatal and childhood) has been linked to cognitive deficits and increased risk 
of depression in adolescents and adults (Joëls & Baram, 2009; Lupien et al., 2009). Moreover, 
the majority (80%) of depressive episodes seems to be preceded by stressful life events 
(Hammen, 2005). The personality trait neuroticism is described as a disposition to report and 
experience negative emotions (Eysenck, 1967). Not only do depression and neuroticism share 
susceptibility genes (Lau & Elay, 2010), depressed persons with high levels of neuroticism also 
have a more chronic course of depression (Mulder, 2002).  
Neurobiological alterations are associated with depression (for reviews, see Arnone et al., 2012; 
Drevets et al., 2000; Nestler et al., 2002). At the neurotransmitter level, multiple studies have 
shown lowered levels of serotonin, norepinephrine, and dopamine in depression. These 
neurotransmitters are important regulators of bodily functions and behavior. Serotonin regulates 
mood, impulse control, as well as social and goal-directed behaviors (Owens & Nemeroff, 
1994; Savitz et al., 2009). Norephinephrine is released during situations of experienced danger 
or fear in the sympathetic nervous system, and regulates attention, concentration, and states of 
arousal (Ferry et al., 1999). Dopamine regulates motivation, exploratory behavior, learning, and 
reward-mediated behavior (Nestler & Carlezon, 2006). At the brain-systems level, the amygdala 
(regulator of fear and danger responses, located in the limbic system in the temporal lobes) is 
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associated with hyperactivity (Fitzgerald et al., 2008), which in turn is associated with 
hypervigilance and a high degree of stress (McEwen, 2009), whereas the prefrontal cortex is 
associated with hypoactivity (Fitzgerald et al., 2008; Ochsner & Gross, 2005). Together, these 
activity alterations in depression imply that the limbic system is overriding the prefrontal cortex, 
which regulates functions such as logical thinking, self-control, self-awareness and executive 
function. This is often referred to as “mood over mind”, so that negative mood may dominate 
the life situation, as opposed to “mind over mood”. At the connectivity level, impaired fronto-
striatal connectivity is a well-documented finding in depression (Arnone et al., 2012; Drevets, 
1999). At the volumetric level, atrophy in hippocampus, basal ganglia, and frontal cortex has 
been observed (Bremner et al., 2000; Lorenzetti et al., 2009). This has consequences for 
cognitive functioning, including domains such as episodic memory, executive function, 
processing speed, and verbal fluency (Alvarez & Emory, 2006; de Quervain et al., 2010; 
Newcomer et al., 1999; Tulving, 2002). Thus, depression is associated with numerous brain 
alterations, although it remains unclear whether depression is the cause or effect of these 
changes. 
The first antidepressant medications emerged in the 1950’s, and guided cellular and molecular 
theories on depression etiology. The “monoamine hypothesis” rests on the assumption that 
depression is the result of functional decline in monamines (e.g., lowered levels of serotonin, 
norephinephrine and dopamine) in specific brain regions (Prange, 1964; Schildkraut, 1965). The 
first drugs was tricyclic agents (TCAs, such as Imipramine; Kuhn, 1958), which inhibits 
reuptake of serotonin and noradrenaline from the synaptic cleft by blocking serotonergic and 
noradrenergic reuptake transporters, respectively. These compounds are still prescribed, but 
rarely as first-line agents, as side effects are substantial. Monoamine Oxidase Inhibitors (MAOs, 
such as Iproniazid; Baiely et al., 1959) also arrived in the 1950’s, and similar to TCAs, they 
have substantial side effects. Selective Serotonin Reuptake Inhibitors (SSRIs, such as Prozac) 
were introduced in 1987, and inhibit serotonin reuptake, which in turn increases synaptic 
serotonin levels, causing increased serotonin receptor activation and enhanced postsynaptic 
responses. SSRIs are used as first-line agents in depression treatment today (APA, 2010; 
Socialstyrelsen, 2010). Further development of antidepressants after the SRRIs include 
serotonin-norephinephrine reuptake inhibitors (SNRIs, such as Venlafaxine), and agents 
targeting circadian rhythms (e.g., melatonin release; such as Agomelatine). Other antidepressant 
treatments include transcranial magnetic stimulation (TMS), electro convulsive therapy (ECT; 
used in severe and suicidal depression), and psychotherapy ((e.g., cognitive behavioral therapy 
(CBT), interpersonal therapy (IP), mindfulness-based stress reduction (MBSR), and acceptance 
commitment therapy, (ACT)). MBSR has shown good treatment efficacy in recurrent 
depression (for a review see, Gotink et al., 2015). Despite multiple treatment modalities, 
recurrence rates of depression are high (APA, 2013), and around 30-40% of depressed persons 
are classified as non-responders to antidepressant agents (Kuk et al., 2010; Trivedi et al., 2006). 
Further, there is large variability in treatment response; some persons respond early in the 
treatment course, whereas others do so much later (Keller et al., 2000; Trivedi et al., 2006); 
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some persons do not respond to one pharmacological agent, but to another (Rush et al., 2006), 
other persons do not respond to pharmacological agents at all, but to psychotherapy (Thase et 
al., 2000), and vice versa; and still other persons may need a combination of pharmacological 
agents and psychotherapy in order to reach remission (Keller et al., 2000).  
Taken together, depression is a commonly occurring, seriously impairing, heterogeneous and 
recurrent disorder, accompanied by a multifactorial etiology and neurobiological alterations, 
which is difficult to treat to remission.  
 
1.2 DEPRESSION IN OLD AGE 
Depression is common across the lifespan (prevalence ranges of major depressive disorder: 
children: 0.3-3.0%; youth: 1.9-18.4%; middle-aged: 2-8%; older: 1-9%; Gotlib & Hammen, 
2010; APA, 2013). The distribution is typically U-shaped, with the highest prevalence rates 
among adolescents and older persons (Kessler et al., 1992). Depression is highly distressing in 
all ages, but can be especially problematic in old age when the symptoms most likely add to 
other diseases and physical disabilities (Alexopoulos, 2005; Beekman et al., 2002; Gottfries, 
2001), such as cardiovascular diseases and loss of hearing and vision. Older persons are less 
likely to report affective symptoms (i.e. the cardinal symptoms of depression; Brodaty et al., 
2001; Gallo et al., 1997) and more likely to report psychosomatic complaints (Hegeman et al., 
2012). As a consequence, old-age depression is often both underrecognized and undertreated 
(Cole et al., 1999; Reynolds et al., 2001). Furthermore, depression in old age has negative 
impacts on quality of life, global functioning, and physical health (Koenig et al., 2014). 
Prevalence of mild depression in older ages in the general population is higher (8-14%) 
compared to moderate and severe depression (1-9%). Importantly, if mild depression is 
undetected, and thus left untreated, about 25% will develop moderate depression within 2 years 
(Alexopoulos, 2005). In the oldest old (85+), depression can affect as many as 29% (Bergdahl 
et al., 2007), and this is also an age when suicide rates increase (Wang & Blazer, 2015). 
Furthermore, in hospitalized and nursing home patients depression prevalence may be as high 
as 40% (Beekman et al., 2002). There are reports that older women are still twice as often 
affected in comparison to men (Blazer, 2003), but also reports on greatly reduced gender 
differences in aging (Steffens et al., 2009).  
The course of depression in old age is often more chronic as compared to midlife depression, 
and also more difficult to treat to remission (Beekman et al., 2002; Koenig et al., 2014), due to 
comorbidity and cognitive deficits (Blazer et al., 2003).  
Older persons with depression differ in several respects, particularly in terms of psychiatric 
history and comorbidity (Taylor, 2014). It is therefore important to distinguish between late-
onset (LOD) and early-onset depression (EOD, i.e., recurrent depression). The definition of 
LOD usually varies between onsets after the age of 50-65 years (Herrmann et al., 2007). 
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Individuals with LOD have lower rates of family history with depression (Devanand et al., 
2004), and higher prevalence of dementia (Alexopoulos, 2003) as compared to those with EOD. 
Furthermore, comorbidity of medical diseases and other psychiatric disorders may influence the 
manifestation of depression in an older person’s life (Baune et al., 2009).  
Increasing age is a well-known risk factor for dementia (Raber et al., 2004), and depression is 
associated with an increased risk of dementia (Byers & Yaffe, 2011; Saczynski et al., 2010). 
Also, 30-50% of persons with Alzheimer’s disease have significant depressive symptoms 
(APA, 2000). This is yet another reason why old-age depression differs from depression earlier 
in life. This makes the study of depression in old age highly important, especially as the 
proportion of older individuals is increasing all over the world (Christiansen et al., 2009). This 
population is highly vulnerable due to the frequency of other diseases and physical disabilities, 
as well as vulnerabilities associated with the aging brain. As such, depression adds to a 
challenging life situation in senescence.  
 
1.3 COGNITION 
“Cogito ergo sum” – “I think therefore I am.” These highly cited words were stated by the 
philosopher René Descartes (1596-1650). However, as the neurologist Antonio Damasio 
suggested in his book Descartes’ error, it might be more correct to state: “I have a brain, 
therefore I think” (Damasio, 1995). 
The term cognition (derived from the latin verb cognoscere, con with and gnosco know; “to 
know”) may be described as knowledge-related mental information processing; the way we 
human beings attend to, work with, store, and retrieve information. Our senses (vision, hearing, 
taste, smell, touch) are information receivers, but the ability to comprehend information is a 
complex interplay of brain processes. Cognition includes areas such as planning, decision 
making, problem solving, reasoning, remembering, and language production, and can be 
conscious as well as unconscious (or effortful vs. automatic). According to connectionist 
models, cognition is thought to consist of assemblies of brain connections, where one node is 
connected to other nodes in large networks (McClelland, 1988). Cognitive abilities are the 
underlying brain functions that make it possible to think, remember, and learn. Hence, cognitive 
skills greatly contribute to an individual’s ability to function in everyday life. 
Below follows an overview of the cognitive domains examined in this thesis, all of which were 
investigated using emotionally neutral stimuli.  
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1.3.1 Processing speed 
The ability to process information at a speedy rate enables grasping of knowledge faster, and 
thus, facilitates learning. Processing speed can be described as cognitive efficiency or 
proficiency; the ease with which something is processed. It has been proposed that age-related 
differences in cognitive performance to a large part may stem from decreased processing speed 
(Salthouse, 1992). 
 
1.3.2 Attention 
Attention may be described as the ability to attend to some things while ignoring others, and is 
assumed to be limited in capacity (Pashler et al., 2001). We make a selection of where to direct 
our awareness, but our attention may also be reflexive, such as when a loud noise disrupts a 
conversation, and we momentarily look for the source of the noise to evaluate if it is dangerous 
or not. In other words, attention may be described as how the brain controls its own information 
processing (Chun et al., 2011). This process may affect how we encode and analyze sensory 
inputs, and consequently act on it.   
 
1.3.3 Executive functioning 
Executive functions, also referred to as cognitive control, involve multiple top-down effortful 
mental processes (Diamond, 2013). Building on Baddeley and Hitch’s (1974) multicomponent 
model of working memory (see below), Miyake and colleagues (2000), proposed a theory on 
how the central executive controls the two slave systems (phonological loop and visuospatial 
sketchpad). Executive control was proposed to be exerted via three core functions: shifting 
(between tasks or mental sets), updating (refreshing and monitoring of working memory 
representations), and inhibition (suppression of dominant, automatic or prepotent responses). In 
this thesis, only shifting was examined.  
 
1.3.4 Memory 
Oscar Wilde (1854-1900) eloquently described memory as “the diary we all carry with us”. 
Memory involves encoding, storing, and retrieving information. Our sense of self, our identity, 
we consequently owe to our memory.  
Memory consists of process-related systems. The notion of multiple memory systems, and 
interactions between them, is nowadays widely accepted (Eichenbaum & Cohen, 2001; Squire, 
2004). However, there still remains uncertainty about the exact number of memory systems.  
A commonly used distinction is that between nondeclarative (not examined in this thesis) and 
declarative memory (Atkinson & Shiffrin, 1968; Squire 1993). Nondeclarative memory consists 
of procedural memory (learning of motor skills, such as walking, and riding a bike – behaviors 
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that after acquisition becomes automatic) and the perceptual representation system (PRS), also 
referred to as priming. Nondeclarative memories are typically out of reach of conscious 
awareness (i.e., no mental effort is needed, for example, we do not need to ask ourselves “how 
is this done?” every time we ride a bike or drive a car). Declarative memory may further be 
divided into short-term and long-term memory.  
 
1.3.4.1 Short-term memory 
Short-term memory is the retention of information over seconds to minutes (Jonides et al., 
2008). This memory system is assumed to be limited, and the number of items that can be 
retained has been proposed to be 7 +/- 2 (Miller, 1956). An example of short-term memory is 
the retention of a phone number. In addition to storage, working memory, also involves 
performing mental operations (i.e., manipulations). Baddeley and Hitch (1974) proposed a 
cognitive framework of a three part working memory system consisting of a central executive 
function (see above) that controls two subordinate content-specific systems: the phonological 
loop (rehearsal) and the visuospatial sketch pad (visuospatial information storage). In 2000, an 
episodic buffer was added to this working memory model (Baddeley, 2000), a component that 
binds the various content types together.  
 
1.3.4.2 Long-term memory 
Long-term memory is the retention of information over days and years, and is typically 
subdivided into episodic and semantic memory (Tulving, 1972). Both memory systems involve 
conscious recollection of stored information, but differs in their content. Episodic memory 
stores personal events that specifies what, when and where, and has further been described as 
mental time travelling (Tulving, 2002). An example of an episodic memory is when and where 
the last vacation was spent, what activities were performed, and other types of contextual 
information (e.g., persons present, weather conditions, etc.). Episodic memory is highly 
sensitive to aging (Rönnlund et al., 2005), and among the first cognitive domains affected in 
dementia (Bäckman et al., 2005). Semantic memory, in turn, concerns the recollection of factual 
knowledge. Examples of semantic memory are recollections of bird species, reciting a poem, or 
naming the highest mountains on every continent.   
 
1.3.5 Verbal fluency 
Language encompasses abilities such as production of speech, writing text, and comprehension 
of spoken and written words (Strauss et al., 2006). Verbal fluency may be described as the 
production of a series of words, and typically also taxes other cognitive domains such as 
executive functioning and processing speed (Lezak, 2005). 
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1.3.6 Spatial ability 
Spatial ability has been described as the capacity to comprehend and remember spatial 
relationships among objects (Webb et al., 2007). Spatial skills are important in many areas, such 
as mathematics and engineering (Wright et al., 2008), and encompasses tasks such as driving a 
car, building a house, or assembling IKEA furniture.  
 
1.4 COGNITIVE PERFORMANCE IN OLD-AGE DEPRESSION 
Depression frequently presents with cognitive deficits in all ages (for a review on research with 
younger adults, see Castaneda et al., 2008). Cognitive deficits in depression have been shown to 
contribute to poor functioning independent of affective symptoms (Jaeger et al., 2006), affecting 
situations in daily life, such as maintaining household and interpersonal relationships. 
Importantly, cognitive deficits in depression are associated with higher rates of recurrence 
(Fossati et al., 2002; Majer et al., 2004), longer episode durations and reduced remission rates 
(McCall & Dunn, 2003; Papakostas, 2014), reduced coping abilities and treatment compliance 
(Dunkin et al., 2000), poorer antidepressant treatment response (Koenig et al., 2014; Morimoto 
& Alexopoulos, 2015), and greater overall disability (Koenig et al., 2014). Thus, cognitive 
deficits in depression are associated with poor prognosis. 
Underdetection of depression in older ages is a common problem (Cole et al., 1999; Reynolds et 
al., 2001), as this population is less likely to report mental health symptoms (Brodaty et al., 
2001; Gallo et al., 1997), and more likely to report psychosomatic symptoms compared to their 
younger counterparts (Hegeman et al., 2012). A factor that further complicate diagnosis of 
depression in older ages is that depressive symptoms may be conceived of as something 
“normal” in late life (Netuveli et al., 2006). Thus, at a time when spouses and friends may have 
poor physical health and die, when an older person’s physical body may limit activities that 
previously were easily accomplished and enjoyed, and when normal cognitive decline is 
frequently occurring ─ depressive symptoms may be overlooked rather than attended to ─ both 
by the person experiencing them, and by the examining doctor. Furthermore, depression-related 
cognitive deficits in older ages may mimic dementia-related problems, as episodic memory 
deficits characterize both dementia and depression (Bäckman et al., 2005; Potter & Steffens, 
2007; Veiel, 1997). Thus, persons who should be diagnosed with depression may be wrongly 
diagnosed with dementia, a phenomenon known as “pseudo dementia” (Fischer, 1996). These 
problems makes it especially important to extend the knowledge on cognitive performance in 
old-age depression.  
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1.4.1 Cognitive deficits during an acute episode  
Multiple cognitive domains are affected in old-age depression. Deficits have been reported in: 
processing speed (Beats et al., 1996; Butters et al., 2004; Kramer-Ginsberg et al., 1999; Köhler 
et al., 2010; Nebes et al., 2000); attention (Ganguli et al., 2009; Thomas et al., 2009); executive 
functions (Beats et al., 1996; Baudic et al., 2004; Butters et al., 2004; Elderkin-Thompson et al., 
2004; 2007; Lockwood et al., 2002; Nebes et al., 2003; Sheline et al., 2006); episodic memory 
(Bäckman et al., 1994; 1996; Kramer-Ginsberg et al., 1999; Sheline et al., 2006; Veiel, 1997); 
semantic memory (Bhalla et al., 2006; Sheline et al., 2006; Zakzanis et al., 1998); verbal 
fluency (Beats et al., 1996); and visuospatial ability (Bhalla et al., 2006; Elderkin-Thompson et 
al., 2004; Lesser et al., 1996; Thomas et al., 2009). However, there are also numerous reports 
of lack of cognitive deficits in these domains: processing speed (Boone et al., 1995); executive 
functions (Baune et al., 2006; Boone et al., 1995; Elderkin-Thompson et al., 2007); episodic 
memory (Baune et al., 1996); and semantic memory (Butters et al., 2004; Ravdin et al., 2003). 
Moreover, some reports of complete absence of cognitive deficits also exists (Fisher, et al., 
2008; Krogh et al., 2012).  
Hence, cognitive deficits in depression differ both between and within studies. The large 
heterogeneity of cognitive deficits in old-age depression may originate from multiple factors 
acting as modulators: clinical factors, including age of onset and cumulative illness burden 
(Hasselbalch et al., 2013), depression severity (McDermott & Ebmeier, 2009), comorbidity 
(Baune et al., 2009), inpatient versus outpatient status (Lee et al., 2012), medication status 
(Porter et al., 2003); demographic factors, including gender (Halpern et al., 2007; Miller & 
Halpern, 2014), education and age (Rönnlund et al., 2005); health behaviors, including 
exercise (Colcombe & Kramer, 2003); and the presence of risk alleles of cognitively relevant 
genes (Laukka et al., 2013; Papassotiropoulos, 2006).  
 
Research on the influences of these factors on cognitive performance in old-age depression is 
scarce. Therefore, it is important to extend our knowledge of the influence of both depression-
related factors modulating cognitive performance in old age, as well as the influence of 
demographic and other factors previously known to affect cognitive performance in 
nondepressed samples. This is a pertinent issue, as findings on cognitive deficits in old-age 
depression are mixed, and as cognitive deficits in depression have major implications for 
treatment and the likelihood of remission.  
 
1.4.2 Cognitive deficits during remission  
The heterogeneity of cognitive deficits in depression is extended to remission of depression, 
although the bulk of findings demonstrate remaining deficits (for reviews, see Bora et al., 2013; 
Hasselbalch et al., 2011). The majority of evidence on reversibility of cognitive deficits in 
depression stems from younger samples (Biringer et al., 2005; 2007; Gallagher et al., 2007; 
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Hammar & Årdal, 2012; Lahr et al., 2007), although there are  some reports of reversibility in 
old-age depression (Barch et al., 2012; Beats et al., 1996; Story et al., 2008).  
It has been suggested that cognitive deficits in depression are more trait- (stable deficits in both 
acute and remitted states) than state-related (fluctuating between acute and remitted states, i.e., 
somewhat reversible). The most recent review of longitudinal studies, following persons from a 
depressed state to a remitted state, summarized their findings suggesting that attentional and 
executive dysfunctions may be trait-related, whereas deficits in other cognitive domains may be 
state-related (Douglas & Porter, 2009). However, recent findings regarding this question are 
mixed. For example, studies have shown support for executive dysfunction being trait-related 
(Årdal & Hammar, 2011; Koenig et al., 2015), whereas other studies have indicated 
reversibility (Barch et al., 2012; Gorlyn et al., 2015). Furthermore, factors that modulate 
cognitive performance during a depressed state, as described above, may also modulate 
performance in a remitted state.  
As findings on whether cognitive deficits in depression are state- or trait related have been 
mixed, further investigation of this research question is warranted. Notably, if cognitive deficits 
in old-age depression are reversible (i.e., state-related), then they should be regarded as targets 
for treatment, rather than as stable vulnerabilities.  
 
1.4.3 Origins of cognitive deficits  
As noted, cognitive deficits in depression are well-established. Although this research field is 
relatively young, and cognitive symptoms are described vaguely in the clinical criterion – 
“reduced concentration and attention” – (ICD-10; WHO, 1993), cognitive deficits are now 
considered a core feature of depression (Köhler et al., 2010).  
There are several theories of the origins of cognitive deficits in depression. One of the earliest 
accounts suggested lack of motivation as the underlying cause (Weingartner et al., 1981). Lack 
of motivation was thought to be associated with lowered drive, and thus associated with 
anhedonia (loss of interest and enjoyment). Relatedly, it has been suggested that studying 
depression is, to some extent, to study reduced motivation (Austin et al., 2001). The typical way 
to examine lack of motivation was to use tasks measuring lack of response to monetary reward 
(Richards & Ruff, 1989). Typically, depressed persons were less sensitive to reward as 
compared to nondepressed.  
Another notion is based on the distinction between effortful and automatic processing, where 
the first category was assumed to be impaired, whereas the other was not (Denny & Hunt, 1992; 
Hertel & Hardin, 1990). The reason for this pattern was thought to be reduced attentional 
capacity in depression (Hasher & Zacks, 1979). However, both these theories have been refuted 
(Austin et al., 1992; 1999; Brown et al., 1994; Kindermann & Brown, 1997), and cognitive 
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deficits in depression are no longer considered epiphenomena of poor motivation or attentional 
capacity. 
More recent theories on the origins of cognitive deficits in depression include stress. The 
overdrive of the Hypothalamic-Pituitary-Adrenal axis (HPA), is a well-documented finding in 
depression (Pariante & Lightman, 2008) and an essential feature of stress (Sapolsky, 2000a). 
The HPA-axis overdrive leads to excessive levels of cortisol, which in turn may have 
detrimental effects on episodic memory and other cognitive domains (de Quervain et al., 2010; 
Howland & Yang, 2008; Newcomer et al., 1999; Schwabe et al., 2010), due to hippocampal 
atrophy following the cortisol cascade (Sapolsky, 2000b). It has further been shown that the 
prefrontal cortex is even more sensitive to the negative effects of stress compared to the 
temporal lobes (Lupien et al., 1999; Young et al., 1999), which may have implications for 
cognitive domains such as executive function, attention, processing speed, and verbal fluency 
(Alvarez & Emory, 2006). Thus, elevated and prolonged stress may be a key factor in the 
origins of cognitive deficits in depression.  
As mentioned, there are at least two types of depression in older ages: recurrent depression 
(EOD) and the development of a first depressive episode (LOD). These two types of depression 
have been suggested to differ in their neurobiology. LOD has been associated with white-matter 
lesions, whereas EOD may be more associated with stress-related neurotoxicity resulting in 
hippocampal atrophy (Janssen et al., 2007; Rapp et al., 2005). Furthermore, the vascular 
depression hypothesis formulated, by Alexopoulos and colleagues (1997; 2006), states that 
cerebrovascular disease and white-matter hyperintensities often precedes LOD (for a review, 
see Herrmann et al., 2008). LOD has been associated with higher prevalence rates of dementia 
(Alexopolous, 2003), and LOD also has weaker genetic link to depression than EOD (Devanand 
et al., 2004). The pattern of cognitive deficits in EOD and LOD may differ, as there might be 
neurobiological differences exerting differential effects on cognitive performance. Specifically, 
LOD has been suggested to have pronounced executive dysfunction (Alexopolous, 2003; Rapp 
et al., 2005), whereas EOD has been suggested to have pronounced episodic memory deficits 
(Jansen et al., 2007; Rapp et al., 2005; Salloway et al., 1995).
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2 AIMS 
The overall aim of the present thesis was to investigate cognitive performance in unipolar 
depression in older dementia-free persons (≥60 years). We examined a range of factors that 
might contribute to the high variability of observed cognitive deficits in old-age depression 
(Studies I, II, and III), and which cognitive deficits may be reversible upon remission from a 
depressive episode (Studies III and IV). The specific research aims were: 
Study I: To assess the influence of depression severity on cognitive deficits in dementia-free 
older persons with unipolar depression, while controlling for a range of clinical (psychiatric 
comorbidity, antidepressant medications, prodromal dementia) and demographic (age, 
gender, education) factors that may influence cognitive performance. 
Study II: To examine the role of the combination of KIBRA and CLSTN2 risk alleles on 
episodic memory performance in dementia-free older persons with unipolar depression. 
Study III: To investigate the effects of psychiatric history (in- and outpatient), including 
psychiatric comorbidity, on cognitive performance in dementia-free older persons during 
acute and remitted states of depression. 
Study IV: To assess level and change in cognitive performance in dementia-free older persons 
in three courses of unipolar depression (from depressed to remitted; from remitted to 
depressed, and from a nondepressed state to late-onset depression) over a maximum period of 
6 years. 
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3 MATERIALS AND METHODS 
3.1 THE SNAC-K STUDY  
All studies in this thesis were based on SNAC-K, which is a longitudinal population-based 
study comprising an extensive medical, social, and psychological data base. The overall aim 
of SNAC-K is to increase the understanding of aging processes and to identify potential 
preventive strategies to improve health and care for older adults. 
Participants were randomly selected (based on birth dates) from elderly persons (≥ 60 years) 
registered as residents in the Kungsholmen municipality of Stockholm, Sweden. At baseline, 
between 2001 and 2004, there were 4590 eligible participants. In total, 3363 persons 
completed baseline assessments. Reasons for non-participation included: refusal: 25%; 
refusal by relative: 1%; and disrupted examination: 0.004%. Data were collected using 
clinical examinations and structured interviews, self-report questionnaires, and administration 
of an extensive neuropsychological test battery. Altogether, the examinations (physician, 
nurse, and psychologist) take approximately 6 hours at each data collection wave.  
At baseline, 2848 participants completed neuropsychological testing. Reasons for non-
participation included: refusal: 12%; Mini Mental State Examination (MMSE; Folstein et al., 
1975) < 10: 3%; death: 0.3%; and other reasons: 0.3%. 
All participants belong to pre-specified age cohorts (60, 66, 72, 78, 81, 84, 87, 90, and 90+ 
years). Younger cohorts (60-72 years) are re-examined at 6-year intervals and older cohorts 
(≥ 78 years) at 3 year-intervals. In total, 1960 persons (68.8%) completed neuropsychological 
testing at follow-up after 3 or 6 years. Reasons for non-participation at follow-up included 
death: 13.8%; refusal: 13.2%; moved/no contact: 2.8%; MMSE < 10: 1.2%; and other 
reasons: 0.1%. 
Participants not belonging to the target group (i.e. depression) were used as reference groups 
for Study I and II. The comparison groups were screened for dementia, psychiatric disorders, 
antidepressant medications, and MMSE < 24. Thus, participants with any of these factors 
were excluded. For Study III and IV, thoroughly screened healthy control groups were 
created. This was done in a two-step procedure. First, dementia-free, nondepressed 
participants were screened for self-reported history of other psychiatric disorders, as well as 
for psychiatric inpatient history, stroke, cancer, Parkinson’s disease, diabetes, and 
medications that may influence cognitive performance (psychotropics, opiods, antiepileptics, 
glucocorticoids, anticholinergics), MMSE < 24 and prodromal dementia. Second, from the 
screened healthy participants a random sample was selected. For Study IV, an additional step 
was taken: The screened healthy participants were also matched on age, gender, education, 
and follow-up time to the depressed groups. 
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3.2 DEPRESSION DIAGNOSIS 
ICD-10 criteria (WHO, 1993) were used to diagnose unipolar depression. The same 
procedure was applied for both baseline and follow-ups, by the same geriatric psychiatrist. 
The diagnosis was made using a three-step procedure. First, the examining physician 
assessed depressive symptoms using the Comprehensive Psychopathological Rating Scale 
(CPRS; Åsberg et al., 1978). The CPRS is a rating scale of current psychiatric symptoms 
such as low mood, anhedonia, low self-esteem, pessimistic view of the future, and suicidal 
ideation. The CPRS has been validated for research and shown to be reliable and sensitive 
(Amati, et al., 1978; Montgomery et al., 1978a; 1978b; Perris, 1979). Furthermore, the 
CPRS has been successfully employed in elderly samples (Bäckman et al., 1996; Berger et 
al., 1998). As a second step, a geriatric psychiatrist, external to the medical examination, 
diagnosed unipolar depression, including mild, moderate and severe depression. Severity of 
depression was assessed using both number of symptoms (mild: 4; moderate: 5-7; severe: 
8+), and reported intensity of the specific symptoms (ranging from 0-6). Indicative of 
pathology, only severity ratings of 2 and above were used (Åsberg et al., 1978). Thyroid 
function was assessed via peripheral blood samples (TSH: 0.4-4.0 µU/ml; total T4: 4.7-13.5 
µg/dl; free T4: 0.8-1.9 ng/dl). Information was also collected via self-report questionnaires 
(including potential bereavement). Persons with abnormal thyroid function and/or 
bereavement were not diagnosed with depression. Third, in case of disagreement between 
different sources of information, a senior geriatric psychiatrist was consulted to confirm or 
reject the initial diagnosis. The psychiatrists were blind to general health status, medical 
and psychiatric history, as well as to pharmacological treatment. 
 
3.3 DEMENTIA DIAGNOSIS 
DSM-IV criteria (APA, 2000) were used to diagnose dementia. The same three-step 
procedure was applied for both baseline and follow ups. First, a preliminary dementia 
diagnosis was made by the examining physician. Second, an independent diagnosis was made 
based on computerized data by a physician who did not meet with the participant. This 
diagnosis was compared to the first diagnosis, and in case of disagreement, a third senior 
physician was consulted to make the final diagnosis. MMSE, the Clock test (Manos & Wu, 
1994), and cognition-related questions regarding orientation, memory, interpretation of 
proverbs, executive functioning, and problem solving were used for diagnostic purposes. The 
physicians were blind to the results of the neuropsychological testing.  
For all studies in this thesis, participants with dementia were excluded. Participants who were 
non-demented at baseline, but diagnosed with dementia during the follow-up period were 
considered to be in a prodromal dementia phase at baseline. For Study IV, where longitudinal 
assessment was carried out, all persons (healthy controls and depressed) with a dementia 
diagnosis at follow-up were also excluded.  
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3.4 NEUROPSYCHOLOGICAL TEST BATTERY 
The neuropsychological test battery was designed in three different versions in order to 
minimize practice effects, and administered according to two different test orders. Trained 
psychologists administered the neuropsychological test battery following a standardized 
procedure, and total testing time was approximately 1.5 hours.  
Processing speed was assessed by pattern comparison and digit cancellation. For pattern 
comparison (Salthouse & Babcock, 1991), participants were presented with 30 pattern 
combinations and asked to, as fast as possible, determine whether these patterns were exactly 
the same or not. The outcome score was the average number of correct responses across two 
trials, each lasting 30 seconds. For digit cancellation (Zazzo, 1974), participants were 
presented with a paper with eleven rows of digits in random order (1-9), and asked to cross 
out the target digit (4) as fast as possible. The outcome score was the total number of correct 
responses within 30 seconds.    
Short-term memory was assessed with digit span (WAIS III; Wechsler, 1981). For digit span 
forward, participants were asked to verbally repeat the digit sequences that the test leader 
read aloud, whereas for digit span backwards, participants were asked to verbally repeat the 
digit sequences backwards. The outcome scores were number of correct repetitions for 
forward and backward span, respectively.  
Attention and executive function were assessed with the Trail Making Test (TMT; Lezak, 
2004). TMT-A was used to assess attention, and TMT-B assessed executive function 
(shifting). Both parts consisted of 13 circles with equal distances between the circles. For 
TMT-A, participants were required to connect the encircled digits in numerical order (1, 2, 3, 
etc.), whereas for TMT-B participants were required to connect the encircled digits and letters 
in alternating order (1-A, 2-B, 3-C, etc.). The test administrator corrected the first mistake, 
which did not result in a lower score (correction time was not included in completion time), 
and one careless connection (>2 mm) was allowed. The outcome scores were completion 
times for participants with 12 correct connections.  
Letter and category fluency (Lezak, 2004) assessed verbal fluency. Letter fluency required 
oral generation of as many words as possible during 60 seconds beginning with the letters F 
and A, respectively. The same procedure was used for category fluency, with occupations and 
animal names serving as taxonomic categories. The outcome scores were the total number of 
generated words divided by two.  
Tests of free recall and recognition were used to assess episodic memory. A standard list of 
16 unrelated nouns (e.g. carrot, ring, fork) was read aloud by the test leader, and participants 
were asked to verbally repeat as many of the words as possible within 2 minutes. The free 
recall outcome score was number of correctly recalled nouns. Immediately following the free 
recall test, 32 nouns were presented (16 targets, 16 lures) and the participants’ task was to 
determine whether or not the words had been presented previously (yes or no). The outcome 
score for the recognition task was number of hits minus number of false alarms.        
 18 
Semantic memory was assessed by a vocabulary test and a test of general knowledge. For the 
vocabulary task, participants were asked to select synonyms for 30 words out of 5 alternatives 
(SRB:1; Dureman, 1960; Nilsson et al., 1997). The outcome score was number of correctly 
selected synonyms within 7 minutes. The general knowledge test (Dahl et al., 2009) consisted 
of 10 moderately difficult questions (e.g., what is the name of the capital of Uruguay?) with 
two response alternatives, one of which was correct. The outcome score was number of 
correct answers.  
Spatial ability was assessed with a test of mental rotations, a simplified 10-item version of the 
Shepard-Metzler test (1970; Rehnman & Herlitz, 2006; Vandenberg & Kuse, 1971). A target 
figure was presented and the participants’ task was to decide, within 45 seconds, which of 
three other rotated figures equaled the target. The outcome score was number of correctly 
selected figures. 
 
3.5 THE SWEDISH NATIONAL INPATIENT REGISTER 
The Swedish National Inpatient Register (IPR) was used for Study III (basis for group 
formation of psychiatric history) and IV (screening of psychiatric history) and entails 
information on ICD diagnoses requiring hospitalizations. The IPR became national in 1969, 
and from 1987 Swedish physicians are required to report to the register, which has been 
validated for research purposes (Ludvigsson et al., 2011). SNAC-K participants were 
matched to the IPR with personal identity numbers. Thereafter, information on primary 
psychiatric diagnoses was obtained from 1969 to baseline examination (2001-2004), thus 
covering up to a maximum of 35 years. The ICD-8 and -9 primary psychiatric diagnoses were 
converted into ICD-10 categories. All persons with F00-F09 diagnoses (dementia) were 
excluded. 
 
3.6 MEDICATION 
Participants were asked to bring a list of currently used medications (prescription and over-
the-counter drugs) to the medical examination. Information from patient journals was also 
used when participants were living in elderly homes. Information on antidepressant 
medication, including tricyclic agents (TCAs), selective serotonin re-uptake inhibitors 
(SSRIs), and others (e.g. Venlafaxin, Mirtazapin) were used for all studies in this thesis. For 
Studies III and IV, information on medications for psychiatric disorders, other than unipolar 
depression, was also used: lithium, benzodiazepines, and antipsychotics. Additional analyses 
controlling for medications that may have negative effects on cognition (psychotropics, 
opioids, antiepileptics, glucocorticoids, anticholinergics) were applied in Study I. For Study 
III and IV, healthy control groups were screened for these medications.  
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3.7 ADDITIONAL BACKGROUND VARIABLES 
Mini Mental State Examination (MMSE; Folstein et al., 1975) was used in all studies for 
assessment of global cognitive functioning. For Study III, a number of variables that may 
modulate cognitive performance were used: cardiovascular disease burden (composite score, 
ranging from 0-3, of heart failure, ischemic heart disease, and atrial fibrillation); 
cardiovascular risk burden (composite score, ranging from 0 to 5, of hypertension stage 2, 
diabetes, obesity, current smoking, and high cholesterol); physical inactivity (never 
physically active or < 2-3 times per month); and cerebrovascular disease (e.g., stroke). 
Montgomery and Åsberg Depression Rating scale (MADRS; Montgomery & Åsberg, 1979) 
was used in Studies III and IV for assessment of residual depressive symptoms in remission. 
 
3.8 STATISTICAL ANALYSES 
All statistical analyses were conducted in SPSS (IBM SPSS 22). Analyses of variance 
(ANOVAs) and χ2 tests were used to assess group differences in background variables. One- 
two- and three factor, and mixed analyses of covariance (ANCOVAs), were used to assess 
group differences, interaction effects, and change in cognitive performance. For Studies I and 
II, age, gender, and education were used as covariates, and for Studies III and IV, age, and 
gender were used. The rationale behind used covariates were presence of significant group 
differences for these variables. Regression analyses were used in Study III to examine 
contributions from clinical and health indicators that may modulate cognitive performance. 
Additionally, calculations of effect sizes (Cohen’s d, Cohen, 1992) of group differences in 
cognitive performance were conducted in Studies III and IV. 
 
3.9 ETHICAL CONSIDERATIONS 
The ethical committee at the Karolinska Institutet approved the SNAC-K study for baseline 
examinations, and the regional ethical review board approved the follow-up examinations. 
The Helsinki declaration of ethical guidelines was followed throughout all parts of the 
project. Informed consent was obtained from all participants, and all participants were 
informed that they could drop out at any time. If, during examination, the participant 
expressed anguish or discomfort, the interview was terminated. In case of cognitive 
impairment, informed consent was obtained from next-of-kin. 
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4 RESULTS AND OVERVIEW OF STUDIES 
Characteristics of participants in Study I to Study IV are summarized in Table 1, and an 
overview of effect sizes of cognitive deficits are presented in Table 2. 
 
4.1 STUDY I 
Previous studies have shown considerable variability with regard to which cognitive domains 
are affected during a depressive episode in older ages. These inconsistencies may be a 
function of clinical and demographic sample characteristics. Therefore, the rationale behind 
the study was to assess the influence of depression severity in unipolar depression in 
dementia-free older persons, while controlling for a range of potential confounders.  
Participants: Dementia-free participants completing neuropsychological testing at baseline 
examination were screened for antidepressant medication intake and comorbid psychiatric 
disorders (psychotic and bipolar disorders), leaving a study sample of 2486 persons, of whom 
89 were depressed (mild: n=48; moderate/severe: n=41).  
Main results: Persons with moderate/severe unipolar depression exhibited deficits in 
processing speed, attention, executive functioning, verbal fluency, episodic memory and 
vocabulary. Persons with mild depression displayed a deficit in processing speed. No 
depression-related deficits were observed for short-term memory, general knowledge, or 
spatial ability. The observed cognitive deficits were not confounded by dementia or 
prodromal dementia, use of antidepressants, psychiatric comorbidities, use of medication that 
may have a negative effect on cognition (psychotropics including benzodiazepines; opioids; 
antiepileptics; glucocorticoids; and anticholinergics), age, education, or gender.  
Main conclusions: Moderate/severe unipolar depression in old age was associated with 
cognitive deficits in a range of domains, also when controlling for multiple clinical and 
demographic factors that influence cognitive performance. Mild depression was only 
associated with a deficit in processing speed. These findings clearly show that depression 
severity influences the magnitude of cognitive deficits. 
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Table 1. Background variables across all study samples.  
  Mild  
depression 
Age Women Education MMSE Medications 
 n % M (SD) % M (SD) M (SD) (%) 
Study I  53.9         Antidepressants 
Mild depression 48  78.6 (10.3) 68.8 10.7 (4.2) 27.9 (2.3) - 
Moderate/severe depression 41  75.9 (9.0) 58.5 10.5 (3.4) 27.9 (2.1) - 
Nondepressed 2397  72.6 (10.1) 60.7 12.1 (4.3) 28.9 (1.4) - 
Study II  53.2           
Depressed, CC/TT 27  77.8 (9.0) 63.0 11.5 (4.1) 27.7 (2.1) - 
Depressed, CC/any C 7  75.6 (5.2) 85.7 10.3 (3.9) 28.7 (1.7) - 
Depressed, any T/TT 31  77.4 (10.7) 67.7 9.7 (3.4) 27.6 (2.5) - 
Depressed, any T/any C 14  76.1 (10.1) 50.0 10.8 (4.9) 28.9 (1.9) - 
Nondepressed, CC/TT 707  72.5 (9.8) 59.1 12.2 (4.2) 28.9 (1.4) - 
Nondepressed, CC/any C 225  71.7 (10.2) 66.7 12.1 (4.3) 29.0 (1.3) - 
Nondepressed, any T/TT 885  72.4 (10.1) 59.9 12.2 (4.4) 28.9 (1.4) - 
Nondepressed, any T/any C 280  72.6 (10.3) 61.4 12.6 (4.3) 28.8 (1.4) - 
Study III  52.0         Psychiatric 
Depressed, no history 49  80.3 (8.2) 65.3 10.6 (3.8) 27.6 (2.2) 6.1 
Depressed, self-reported history 52  74.5 (10.9) 76.9 10.6 (3.8) 28.5 (1.7) 32.7 
Depressed, inpatient history, mixed diagnoses 20  71.8 (9.8) 55.0 11.1 (4.6) 27.9 (2.5) 65.0 
Remitted, inpatient history, unipolar 38  68.3 (7.9) 60.5 12.0 (3.9) 28.8 (1.5) 39.5 
Healthy controls 96  71.3 (9.9) 58.3 11.7 (4.0) 29.1 (1.3) 0 
Study IV* T1: 40.6  T2: 77.0           
Depressed-Remitted 32  71.8 (9.8) 68.8 11.9 (4.7) 28.7 (1.5) 28.1 
Remitted-Depressed 45  71.2 (9.7) 68.9 12.2 (3.7) 29.2 (1.0) 42.2 
Nondepressed-Depressed 29  76.5 (7.8) 75.9 12.2 (3.8) 29.2 (1.1) 3.5 
Matched healthy controls 106  72.0 (9.5) 73.6 12.7 (3.9) 29.1 (1.0) 0 
Note. M=Mean; SD=Standard Deviation; MMSE=Mini-Mental State Examination; Antidepressant medications: tricylic agents, selective serotonin reuptake inhibitors; and others 
such as Mirtazapin, Venlafaxin: Psychiatric medications: antidepressants, antipsychotics, lithium, benzodiazepines; *=baseline values
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Table 2. Effect sizes (Cohen’s d) of significant cognitive deficits across all studies. 
 Processing speed Attention Executive function Verbal fluency Episodic memory Semantic memory 
 Pattern Digit TMT-A TMT-B Letter Category Free recall Recognition Vocabulary 
Study I          
Mild depression 0.58         
Moderate/severe depression 0.57 0.64 0.55 0.45 0.42 0.76 0.63 0.51 0.46 
Study II*          
Depressed, CC/TT       0.94 0.74  
Depressed, CC/any C          
Depressed, any T/TT          
Depressed, any T/any C          
Study III          
Depressed, no history  1.13 1.00 0.61 0.59 0.66 0.80    
Depressed, self-reported history 0.50         
Depressed, inpatient history, mixed 0.63 0.50  0.85 0.66 0.88    
Remitted, inpatient history, unipolar          
Study IV          
Depressed-Remitted, T1  0.63  0.45      
Depressed-Remitted, T2  0.49a 0.35b       
Remitted-Depressed, T1  0.31        
Remitted-Depressed, T2  0.59 0.53 0.31c      
Nondepressed-Depressed, T1    0.63      
Nondepressed-Depressed, T2  0.58 0.71 0.62  0.85    
Note. *=only episodic memory was assessed; controlled for use of benzodiazepines;a=d=0.40; b=n.s., d=0.23; c=n.s., d=0.14.
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4.2 STUDY II 
Kidney and brain expressed protein (KIBRA, rs7070145, a C > T substitution), and 
Calsyntenin 2 (CLSTN2, rs6439886, a T > C substitution) have both been identified as 
episodic memory-related genes. Research on these genes has yielded mixed results, including 
performance advantages in episodic memory of the KIBRA T-allele and CLSTN2 C-allele, 
respectively, as well as non-associations. Furthermore, the potentially added performance 
advantage of the KIBRA T-allele in combination with the CLSTN2 C-allele has also shown 
mixed findings. The resource-modulation hypothesis postulates that loss of resources (i.e., 
due to aging), may magnify effects of allelic variation on cognitive performance. 
Furthermore, reports of episodic memory deficits in old-age depression are common. 
Therefore, it was hypothesized that the combination of disadvantageous KIBRA and CLSTN2 
alleles in persons with old-age unipolar depression would lead to especially poor episodic 
memory performance.  
Participants: Dementia-free participants who had completed neuropsychological testing at 
baseline and been genotyped for KIBRA and CLSTN2 were screened for antidepressant intake 
and comorbid psychiatric disorders (psychotic and bipolar disorders), leaving a study sample 
of 2170, of whom 79 were depressed. Participants were grouped according to depression 
status (yes/no) and genotype combinations (KIBRA: CC, any T; CLSTN2: TT, any C), 
resulting in eight groups (nondepressed/depressed; KIBRA/CLSTN2 carriers of: CC/TT; 
CC/any C; any T/TT; and any T/any C). 
Main findings: Three-way interaction effects of depression x KIBRA x CLSTN2 for both free 
recall and recognition showed that the combination of disadvantageous alleles (KIBRA: CC, 
CLSTN2: TT) was associated with poorer episodic memory performance only in depressed 
older persons; depressed CC/TT carriers consistently performed at the lowest levels. 
Main conclusions: The finding of impaired episodic memory performance only in depressed 
older persons carrying risk alleles of KIBRA and CLSTN2 supports the notion that effects of 
genetic polymorphisms on cognitive performance may be most easily disclosed at suboptimal 
levels of cognitive ability, such as in old-age depression. These results show that memory-
related genes influence cognitive performance in depression, and that this effect may be 
exacerbated in older ages.  
Implications: Older depressed persons carrying disadvantageous memory-related alleles are 
more likely to present with cognitive deficits. This further underscores the importance of 
early detection of depression. 
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4.3 STUDY III 
Cognitive deficits in old-age depression vary as a function of multiple factors, such as 
depression severity, inpatient status, and cumulative illness burden. The heterogeneity of 
cognitive deficits present during acute versus remitted states has raised the question of 
whether these deficits are state- (fluctuating with clinical state) or trait-related (stable 
vulnerabilities). A limitation of previous research is short follow-up time, which may partly 
explain findings of remaining cognitive deficits. The objective of this study was to assess the 
influence of psychiatric history on cognitive performance in dementia-free older persons 
during acute and remitted states of depression. Inpatient history was obtained from the IPR, 
covering up to 35 years, and self-reported history was obtained during the SNAC-K medical 
examination.  
Participants: Four groups were identified, based on psychiatric history and current depression 
status: (1) late-onset unipolar depression, no history; (2) recurrent unipolar depression, self-
reported history; (3) depressed with a recurrent mix of psychiatric disorders, inpatient history; 
and (4) remitted unipolar depression, inpatient history. These four groups were compared to a 
group of randomly selected healthy controls. 
Main results: Depression-related cognitive deficits were observed in processing speed, 
attention, executive function, and verbal fluency among currently depressed persons. 
Currently depressed with a psychiatric inpatient history and persons with late onset 
depression performed at the lowest levels, whereas cognitive performance in persons with 
self-reported recurrent unipolar depression was intermediate. Remitted unipolar depression 
exhibited no cognitive deficits, possibly due to the extended time since their last admission 
(m=15.6 years). Physical inactivity, cumulative inpatient days, heart disease burden and 
prodromal dementia modulated the observed group differences in cognitive performance.  
Main conclusions: Currently depressed persons displayed deficits in multiple cognitive 
domains, and those with a psychiatric inpatient history, or late-onset depression performed at 
the lowest levels. Cumulative psychiatric illness may account for the poor cognitive 
performance of the former group, whereas for the latter, heart disease burden and prodromal 
dementia were shown to modulate cognitive performance. Cognitive recovery may take 
longer time as compared to recovery of depressive symptoms. Taken together, the present 
data suggest that cognitive deficits in depression may be more state- than trait-related. Thus, 
cognitive deficits in depression seem reversible.   
Implications: Relapse rates in depression remain high, and cognitive deficits are associated 
with poor prognosis, and may take longer time to recover. Therefore, combined profiles of 
psychiatric history, cognitive performance, and health behaviors may provide important clues 
for more individualized treatments.  
 
  25 
4.4 STUDY IV 
The episodic nature of depression makes repeated assessments of cognitive performance 
important in order to investigate which deficits are state- (fluctuating with clinical state) or 
trait-related (stable vulnerabilities). Previous studies have shown mixed findings regarding 
which cognitive deficits are present during acute and remitted states, and a limitation is that 
most studies are cross-sectional. The rationale of this study was to investigate state- versus 
trait-related aspects of cognitive deficits in old-age depression with repeated assessment of 
cognitive performance across the same persons over a maximum period of 6 years.   
Participants: Dementia-free participants who had completed neuropsychological testing at 
both baseline (T1) and follow-up (T2) formed the basis of the study sample. Participants were 
grouped according to depression status at T1 and T2, and three groups were identified: (1) 
depressed-remitted; (2) remitted-depressed; and (3) nondepressed-depressed. These three 
groups were compared to matched (age, gender, education, and follow-up time) healthy 
controls.  
Main results: Depression-related cognitive deficits were observed for processing speed, 
attention, executive function, and category fluency. The general pattern showed that 
participants deteriorated cognitively. Significant decline was observed for: processing speed, 
executive function, and category fluency, as well as for episodic and semantic memory. 
Persons who changed their status from nondepressed to depressed tended to show 
exacerbated cognitive decline. In remitted states, only processing speed and attention were 
affected. However, these deficits were modulated by benzodiazepine intake.  
Main conclusions: The results support the notion that cognitive deficits in depression are 
more state- than trait-related. Few cognitive deficits were observed in remission. 
Furthermore, persons who at baseline were nondepressed or in a remitted state and later 
developed a depressive episode at follow-up tended to show steeper cognitive decline.   
Implications: As degree of reversibility of cognitive deficits is likely to diminish with age and 
cognitive deficits are likely to be exacerbated with each successive episode, early detection of 
depression is highly important. The findings of this study imply that cognitive deficits in old-
age depression may be reversible. This further suggests that cognitive deficits should be 
viewed as potential treatment targets, rather than as irreversible vulnerabilities. Along these 
lines, repeated assessments of cognitive performance may provide an additional marker of 
treatment response. 
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5 DISCUSSION 
Taken together, the findings of this thesis show that multiple factors influence cognitive 
deficits in dementia-free unipolar old-age depression: depression severity (Study I); 
disadvantageous alleles of memory-related genes (Study II); and psychiatric history (Study 
III). In addition, several other factors, such as cumulative inpatient days, prodromal dementia, 
comorbidity of psychiatric disorders, comorbidity of heart disease, physical inactivity, and 
benzodiazepine drug intake were found to modulate group differences in cognitive 
performance. The complexity of these observed patterns indicate the existence of multiple, 
rather than one “true” manifestation of cognitive deficits in old-age depression. Consistent 
with the notion that depression is a heterogeneous disorder, these factors have likely 
contributed to the high variability of cognitive deficits observed in old-age depression in 
previous research. 
This thesis has furthermore shown that cognitive deficits in depression are more state- than 
trait-related (Study III and IV), and that time spent in remission seems to be a key factor for 
reversibility of cognitive deficits. This finding suggests that cognitive deficits in depression 
should be regarded as treatment targets rather than as stable vulnerabilities.  
 
5.1 DEPRESSION-RELATED COGNITIVE DEFICITS 
The present studies range among only a few to date which investigate cognitive performance 
in old-age depression according to ICD-10 criteria, which allows for distinctions between 
mild, moderate and severe depression. DSM criteria (APA, 2000; 2013) of major depression 
(MDD; five depressive symptoms must be present) are more commonly used. This is an 
important contribution to the literature, because mild depression is not only more rarely 
investigated, it is also more prevalent in older ages. This was reflected by the high proportion 
of mild depression across the four studies. Hence, this thesis extends current knowledge on 
cognitive deficits, including those observed in mild depression. Had DSM-IV criteria been 
used, multiple cases of mild depression would have been neglected (baseline: n=95, 52.7%). 
Across the four studies included in this thesis, depression-related cognitive deficits were 
observed in processing speed, attention, executive function, verbal fluency, episodic memory, 
and semantic memory (vocabulary). These findings are in line with previous research on 
cognitive deficits in old-age depression (Bäckman et al., 1994; Baudic et al., 2004; 1996; 
Beats et al., 1996; Bhalla et al., 2006; Butters et al., 2004; Elderkin-Thompson et al., 2004; 
2007; Ganguli et al., 2009; Kramer-Ginsberg et al., 1999; Köhler et al., 2010; Lesser et al., 
1996; Lockwood et al., 2002; Nebes et al., 2000; 2003; Sheline et al., 2006; Thomas et al., 
2009; Veiel, 1997).  
A semantic memory deficit (vocabulary) was only observed for moderately and severely 
depressed persons (Study I). No general knowledge deficits were observed in any of the four 
studies, in line with some previous reports (Butters et al, 2004; Herrmann et al., 2007; 
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McDermott & Ebmeier, 2009; Ravdin et al., 2003), but in contrast to others (Bhalla et al., 
2006; Sheline et al., 2006). A possible explanation for the lack of general knowledge deficits 
may be that education was controlled for.  
Cognitive deficits observed in Study I and II were not influenced by antidepressant 
medication, as all participants on any such medications were excluded. The proportion of 
dementia-free depressed persons who completed cognitive testing at baseline and used any 
antidepressant medication was low (17.7%). This may be a reflection of underdetection of 
depression in older ages, as SSRIs are first-line treatments (APA, 2010; Socialstyrelsen, 
2010). In Study III and IV, depressed persons on antidepressant medication were included, 
and for these studies, episodic memory deficits were lacking. This finding may partially be 
explained by SSRI medication, as a potential mechanism of action is thought to result from 
increased neurogenesis and HPA-axis reregulation, which may have stabilized 
neurobiological alterations in the temporal lobes (Maglite et al., 2008; Mahar et al., 2014; 
Wilner et al., 2013). Tasks assessing cognitive domains that draw on the prefrontal lobes 
(processing speed, attention, executive function, and verbal fluency) were negatively affected 
across all four studies. This finding is in line with previous research showing that the 
prefrontal lobes are more sensitive to stress compared to the temporal lobes (Lupien et al., 
1999; Ochsner & Gross, 2005; Young et al., 1999). 
Depression severity was further shown to influence cognitive deficits, as more severe 
depression was associated with more severe cognitive deficits (Study I; see Table 2 for effect 
sizes). In a group of mildly depressed persons, processing speed was the only cognitive 
domain affected. This is an important finding, as mild depression is likely to develop into 
more severe depression if left untreated (Alexopolous, 2005), and thus also increases the 
likelihood of exacerbated cognitive deficits. This in turn underscores the importance of early 
detection of depression.  
Importantly, the observed cognitive deficits were not associated with dementia-related 
pathology, as participants with a dementia diagnosis were excluded from all studies. 
However, excluding persons in a prodromal dementia phase showed that the episodic free- 
recall deficit was more related to prodromal dementia than depression (Study I). Excluding 
persons with prodromal dementia also attenuated other cognitive deficits (processing speed, 
attention, executive function and verbal fluency), although group differences were still 
significant for these domains. Additionally, prodromal dementia modulated the attention 
deficit in Study III. This underscores the importance of controlling for dementia-related 
pathology when investigating patterns of cognitive deficits in old-age depression, as there is a 
plethora of research showing cognitive deficits in both dementia (Mathias & Burke, 2009) 
and in its prodromal phase (Bäckman et al., 2005; Laukka et al., 2004). The exclusion of 
persons with a dementia diagnosis may explain the total lack of deficits in short-term memory 
and spatial ability across all studies; findings that contrast with some of previous reports 
(Bhalla et al., 2006; Elderkin-Thompson et al., 2004; Lesser et al., 1996; Thomas et al., 
2009). Further reasons for this discrepancy include: (1) the tests used to measure short-term 
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memory (digit span forward and backward) were not sensitive enough to pick up on 
depression-related deficits; and (2) the mental rotation task used to assess spatial ability 
primarily draws on parietal brain areas (Tagaris et al., 1996; Wendt & Risberg, 1994) rather 
than fronto-temporal regions, which other measurements of spatial ability such as pattern 
recognition and object assembly, are dependent on (Lezak, 2004).  
Disadvantageous alleles of cognition-related genes may exert negative influences on 
performance (McLearn, 2006; Plomin et al., 1994). These effects have been proposed to be 
magnified in aging (Lindenberger et al., 2008; Papenberg et al., 2013; 2015). This assertion 
rests on the assumption that the relationship between genetic variations and brain resources 
are non-linear, so that genetic effects on cognition increase as resources recede from optimal 
levels (e.g., as is the case in aging; Bäckman et al., 2000; Raz et al., 2005). Depression might 
represent an additional vulnerability factor acting on structural integrity of the brain. Indeed, 
disadvantageous alleles of the episodic memory-related genes KIBRA and CLSTN2 were 
linked to episodic memory deficits only in depressed older persons (Study II). This effect was 
not observed in depressed persons without these alleles, reflecting that genetic influences on 
cognitive performance were more pronounced in old-age depression. As such, this makes 
older depressed persons carrying disadvantageous memory-related alleles even more likely to 
present with cognitive deficits.  
Previous research has shown that recurrent episodes of depression exert a negative impact on 
cognitive performance (Robinson & Sahakian, 2008; Stordal et al., 2004; Takami et al., 
2007). The underlying assumption is that cognitive and depressive symptoms worsen with 
each successive depressive episode. In Study III, it was shown that inpatient history and 
comorbidities of bipolar, psychotic, and anxiety disorders, had a larger negative influence on 
cognitive performance during a current depressive episode. Specifically, cumulative load of 
inpatient days exerted negative effects on processing speed and executive function. In 
addition, inpatient history had a greater degree of negative influence than outpatient history 
on cognitive performance, as the group without inpatient history outperformed the group with 
inpatient history in both processing speed and verbal fluency. These findings extends our 
knowledge on cognitive performance in recurrent depression, showing differential patterns of 
deficits as a function of psychiatric history.  
Physical activity is known to have positive effects on cognitive performance in healthy 
(Barnes, 2015), and older (Carvalho et al., 2014; Colcombe & Kramer, 2003) persons, and 
further to have antidepressant effects (Greer & Trivedi, 2009; Hallgren et al., 2015; Wegner 
et al., 2014). The underlying mechanisms are thought to originate from decreased levels of 
damaging effects from oxidative stress, including increased anti-inflammatory processes, 
positive immune function effects, lowered cortisol levels, increased levels of serotonin and 
dopamine, endorphins, and Brain-Derived-Neurotrophic Factor (BDNF; Eyre & Baune, 
2012; Knochel et al., 2012; Meeusen, 2014). As such, physical activity may exert a protective 
influence on the same pathways mediating oxidative stress and inflammation (Munhoz et al., 
2008), making the bodily response from exercise rewarding. Recently, a specific mechanism 
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was discovered in stress-induced depressed rats; during exercise the muscle activity produces 
an enzyme, KAT, which turns the harmful kynurenine molecule into the non-harmful 
kynuerenic acid (Agudelo et al., 2014). Thus, the muscle during exercise can be compared to 
the detoxifying work of the liver. Ergo, exercise supposedly has neuroprotective properties. 
In line with this view, physical inactivity had negative effects on cognitive performance in 
depressed persons (Study III). Hence, depressed older persons not engaging in physical 
activity are more likely to present with cognitive deficits. This point is reinforced by the 
finding that remitted persons with higher proportions of physical activity displayed a total 
lack of cognitive deficits.  
 
5.2 RECURRENT DEPRESSION VS. LATE-ONSET DEPRESSION 
Previous research has suggested that early-onset depression (EOD; i.e., recurrent) and late-
onset depression (LOD; i.e., first depressive episode in older age) may differ both in their 
etiology and neurobiology. Consequently, they have also been suggested to differ in their 
patterns of cognitive deficits.  
Executive dysfunction (Alexopolous, 2003; Rapp et al., 2005) has been suggested to be a 
hallmark feature of LOD as compared to EOD, which may be related to altered white-matter 
integrity (Herrmann et al., 2008) and frontostriatal abnormalities (Sheline et al., 2006). In 
contrast, EOD has been suggested to be linked to episodic memory deficits (Jansen et al., 
2007; Rapp et al., 2005; Salloway et al., 1995), which are thought to originate from 
hippocampal atrophy due to stress from recurrent depressive episodes (Bell-McGinty et al., 
2002; Lampe et al., 2003; Sheline et al., 1999). Findings from Study III and IV are not 
entirely consistent with these assertions; deficits in executive function were observed for both 
LOD and EOD, whereas none of the groups exhibited deficits in episodic memory. However, 
Study IV showed that only in LOD, the observed executive function deficit further 
exacerbated upon depression onset, when also deficits in processing speed, attention and 
category fluency were developed.  
LOD and the EOD group with psychiatric inpatient history exhibited similar patterns of 
cognitive deficits, whereas an EOD group without inpatient history was relatively 
unimpaired, only exhibiting a processing speed deficit (Study III). This processing speed 
deficit was replicated in Study IV for both EOD groups, where they were additionally found 
to exhibit deficits in attention and executive function. Thus, the patterns of cognitive deficits 
for LOD and EOD differed across the two studies.   
Although observed patterns of cognitive deficits in groups of EOD and LOD stand in contrast 
to some previous research (Alexopolous, 2003; Rapp et al., 2005; Salloway et al., 1995), a 
more recent meta-analysis (Herrmann et al., 2007), showed that both EOD and LOD 
displayed deficits in executive function, processing speed, and episodic memory, and that 
LOD exhibited larger effect sizes relative to EOD, with the largest effect size for executive 
function. Thus, in line with our research, executive dysfunction was pronounced in LOD, 
 30 
however, pronounced episodic memory deficits in EOD were not seen in our findings. A 
potential explanation for the lack of episodic memory deficits in EOD in Study III and IV 
may include a dementia-free sample, and the combination of high proportions of mild 
depression (McDermott & Ebmeier, 2009) and antidepressant medication intake (Wilner et 
al., 2013).  
The observed cognitive deficits in the two LOD groups, may also largely reflect dementia-
free samples, which may have confounded previous research. Although the attentional deficit 
in LOD (Study III) was modulated by prodromal dementia, the other deficits were modulated 
by heart disease burden, consistent with the notion that LOD may be preceded by 
cerebrovascular disease (Alexopolous et al., 1997; 2006). Furthermore, prodromal dementia 
may have exerted a larger influence on LOD deficits observed in Study IV, but information 
on future dementia diagnosis was not yet available. Factors speaking in favor of this scenario 
are: (1) marked MMSE decline in this group; (2) presence of an executive deficit before 
depression onset; and (3) the fact that the executive function deficit was more pronounced in 
LOD relative to both EOD groups. Even so, episodic memory deficits were absent for all 
groups in both Study III and IV, a domain known to be one of the first affected in prodromal 
dementia (Bäckman et al., 2005). 
Taken together, these findings suggest that even though EOD and LOD have etiological and 
neurobiological differences, their patterns of cognitive deficits may be both similar and 
different. Specifically, patterns of cognitive deficits in both EOD and LOD seem to vary as a 
function of multiple factors, including psychiatric history, prodromal dementia, and comorbid 
medical diseases.  
 
5.3 COGNITIVE AGING AND DEPRESSION 
Cognitive decline was observed in processing speed, executive function, and category 
fluency, as well as in episodic and semantic memory for three depression courses (depressed-
remitted, remitted-depressed, nondepressed-depressed), as well as for healthy controls in 
Study IV. 
Steeper trajectories of cognitive decline were displayed by persons going from a remitted to a 
depressed state than those going from a depressed state to a remitted state. This finding is in 
line with previous research showing “scarring” from previous depressive episodes (Robinson 
& Sahakian, 2008; Stordal et al., 2004). As normal aging entails deteriorating processes of 
cognitive abilities and brain integrity (Nyberg et al., 2012; Raz et al., 2005), older persons 
suffering from recurrent depression may be especially vulnerable to progressive cognitive 
decline upon entering yet another depressive episode.  
LOD also displayed marked cognitive decline (see Table 2). Potential explanations include 
older mean age and potential prodromal dementia. Depressed-remitted persons displayed 
cognitive decline only in short-term memory and processing speed, possibly reflecting slower 
aging upon entering a remitted state in recurrent old-age depression.  
  31 
Taken together, persons going from a nondepressed state to a depressed state showed the 
largest cognitive decline. Hence, depression in old age seems to exacerbate cognitive aging.   
 
5.4 ORIGINS OF COGNITIVE DEFICITS IN DEPRESSION AND THEIR 
REVERSIBILITY 
Stress is suggested to be a key factor in the etiology of depression. Early exposure to 
adversive stress (prenatal and childhood) has been shown to trigger long-term changes in 
adolescents and adults, involving cognitive deficits, increased risk of depression, and 
compromised regulation of the HPA-axis (Joëls & Baram, 2009; Lupien et al., 2009). 
Moreover, it has been suggested that the majority (80%) of depressive episodes are preceded 
by stressful life events (Hammen, 2005). A potential explanation for this include that early 
adversive life-events alter gene expression involved in bodily responses to threat, injury and 
infection. Thus, stress-induced epigenetic mechanisms (i.e., interactions between nature and 
nurture) have been suggested to mediate vulnerability to depression, and other psychiatric 
disorders (Dudley et al., 2011). As such, origins of cognitive deficits in depression may also 
be stress-related.  
The physiology of stress is a complex interplay of several systems, including endocrine, 
immune, and neurotransmitter systems. In response to stress, the neuroendocrine system is 
activated, specifically the HPA-axis (McEwen, 2009), and hyperactivity of the HPA-axis is 
also a well-known finding in depression (Pariante & Lightman, 2008.) As the HPA-axis is 
activated, corticotrophin releasing factor (CRF) is released from the hypothalamus which 
stimulates the pituitary gland to produce adrenocorticotrophic hormone (ACTH). This in turn 
stimulates the adrenal cortex to release glucocorticoids (cortisol) into the blood circulation. 
Glucocorticoids are important regulators of metabolism and the immune system, and thus 
important for homeostasis. Thus, HPA-axis hyperactivity is a well-known feature during both 
stress and a depressive episode.  
Prolonged stress may induce a vicious neurotoxic circle, which in turn makes coping with 
stress even more difficult. And reduced coping and poor emotion regulation is associated 
with depression (Aldao et al., 2010; Joorman & Gotlib, 2010; Sheppes et al., 2015; Zetsche et 
al., 2012). Furthermore, rumination has also been shown to be stressful and associated with 
increased levels of cortisol (Woody et al., 2015; Zoccola & Dickerson, 2012).  
Both acute and chronic stress are known to activate the immune system inducing pro-
inflammatory states (Munhoz et al., 2008), and inflammation is frequently occurring in 
depression (Maes et al., 2009). High levels of glucocorticoids stimulate the release of pro-
inflammatory cytokines, such as interleukin-6, which further stimulates the HPA-axis 
(Cassidy & O’Keane, 2000; Zunszain et al., 2011). Furthermore, inflammatory cytokines 
have been associated with learning and memory (McAfoose & Baune, 2009). As pro-
inflammatory cytokines can activate neuroendocrine processes, and vice versa, HPA-axis 
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hyperactivity and inflammatory processes may be part of the same stress-induced processes 
(Zunszain et al., 2011).  
The depression-related neurotransmitters serotonin, dopamine, and norepinephrine (lowered 
in depression; Ferry et al., 1999; Nestler & Carlezon, 2006; Owens & Nemeroff, 1994; Savitz 
et al., 2009; Southwick et al., 2005), and stress-related cortisol and CRF, all act in brain 
regions important for cognitive functioning (Alvarez & Emory, 2006; Tulving, 2002) and 
emotion regulation (McEwen, 2009; Ochsner & Gross, 2005). Cortisol, CRF, dopamine and 
serotonin are active in the prefrontal cortex; cortisol and CRF further act in hippocampus, 
amygdala, and hypothalamus; serotonin is active in hippocampus; and dopamine and 
serotonin are both active in the amygdala (McEwen, 2009; McEwen & Morrison, 2013; 
Southwick et al., 2005). Stress is also known to affect regions in prefrontal cortex, including 
the insula and dorsal anterior cingulate cortex, which are involved in self-control, self-
awareness and executive function; and these regions are also known to be affected in 
depression (Arnone et al., 2002; Drevets et al., 2000; Nestler et al., 2002). As such, these 
prefrontal regions could slow down the hyperactivity of the HPA-axis and the amygdala in 
the temporal lobes, but when affected these brakes are less efficient. Depression is 
furthermore associated with atrophy in the prefrontal cortex, basal ganglia and hippocampus 
(Bremner et al., 2000; Lorenzetti et al., 2009). Thus, both stress and depression are associated 
with similar neurobiological alterations. As tasks assessing cognitive domains that draw on 
the prefrontal lobes (processing speed, attention, executive function, and verbal fluency) were 
negatively affected across the four studies in this thesis, this finding is in line with previous 
research showing that the prefrontal lobes are more sensitive to stress compared to the 
temporal lobes (Lupien et al., 1999; Ochsner & Gross, 2005; Young et al., 1999).  
Taken together, there is pervasive evidence that both stress and depression are linked to 
cognitive deficits; they seem to use similar pathways and affect similar brain regions. If 
cognitive deficits in depression is partly a function of the neurotoxic effects of stress, they 
should show some degree of reversibility when stress is discontinued, and when homeostasis 
is somewhat restored (McEwen & Morrison, 2013). As this thesis was able to demonstrate 
reversibility of cognitive deficits (executive function) in depression (Study IV), one 
possibility is that the observed cognitive deficits were related to stress.  
Another finding in support of reversibility of cognitive deficits in dementia-free unipolar old-
age depression is that cognitive deficits were absent in long-term remission of recurrent 
depression (Study III). This suggests that cognitive deficits may be reversed if sufficient time 
is spent in remission. Further support for this reasoning is that physical activity influences the 
same pathways as oxidative stress and inflammation, but in a neuroprotective way. Consistent 
with this notion, physical inactivity exerted negative effects on cognitive performance in 
depressed persons (Study III). This is further supported by the finding that more physically 
active remitted persons displayed complete absence of cognitive deficits. As such, these 
findings do not support the suggestion that deficits in attention and executive function in 
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depression are trait-related (Douglas & Porter, 2009), but rather that cognitive deficits in 
depression are largely reversible (i.e., state-related).  
Numerous factors may modulate brain plasticity, age being a critical one (Coillard-Depres et 
al., 2011). As the aging brain is vulnerable (Bäckman et al., 2000; Raz et al., 2005), reports of 
remaining cognitive deficits during remission in old-age depression (Bhalla 2006; Nebes et 
al., 2003; Portella et al., 2003) may not be surprising. Also, other pathways to cognitive 
deficits in depression, such as dementia and prodromal dementia, may lead to limited 
reversibility. Consequently, studies not controlling for dementia may be more likely to 
support the trait hypothesis.  
In sum, previous findings of persistent cognitive deficits in remitted old-age depression 
(Bhalla et al., 2006; Nebes et al., 2003; Portella et al., 2003) may partly be accounted for by: 
(1) dementia-related pathology; (2) insufficient time spent in remission; and (3) reduced 
plasticity. This is consistent with the observation that most evidence for reversibility of 
cognitive deficits in depression originate from younger samples (Biringer et al., 2005; 2007; 
Gallagher et al., 2007; Hammar & Årdal, 2012; Lahr et al., 2007).  
 
5.5 CONCEPTUALIZATION OF DEPRESSION 
 
“Why is it that when we are talking to God we’re praying,  
but when God talks to us we’re schizophrenic?” 
                                                                       (Psychiatrist Thomas Szaz, 1963) 
Throughout history, conceptualization of depression and other psychiatric disorders has 
presented itself with challenges. In contrast to many medical diseases, mental disorders do 
not have clear physical criteria that may be measured in an objective way. Diagnostic criteria 
of depression, and most psychiatric disorders, rely on reported symptoms, and thus are 
descriptive in nature. For example, we cannot draw a blood sample and from that conclude 
that a person has depression or not, as is the case for a person with diabetes. Instead, 
psychiatric disorders are essentially syndromes, something that Owens (2014) explains as: 
“constellations of signs and symptoms that tend to occur together”. For the new edition of 
DSM-5 in 2013, there was hope that neuroscience would have progressed to the point that 
psychiatric categories could be defined by biomarkers, but this has not yet been realized (e.g., 
Nesse & Stein, 2012). At this point in history, we still face conceptual challenges, as 
knowledge on etiology and biological mechanisms of depression and other psychiatric 
disorders remain insufficient.  
Several theories have tried to explain the etiology of depression: the monoamine hypothesis 
(Prange, 1964; Schildkraut, 1965); cognitive and behavioral theories (vulnerability-stress 
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models; Beck et al., 1979; Bower, 1981); HPA-axis dysfunction theory (Dinan, 1994; 
Pariante & Lightman, 2008); the neurogenesis hypothesis (Jacobs et al., 2005; Petrik et al., 
2012); the inflammatory or cytokine theory (Maes et al., 2009). None of these theories has so 
far been sufficient to explain the etiology of depression. This is reflected in suboptimal 
treatment; 30-40 per cent of depressed individuals do not respond to antidepressant 
treatments (Kuk et al., 2010; Trivedi et al., 2006), and augmented or sequenced treatment 
alternatives have also shown poor remission rates (Rush et al., 2006). Despite prolific 
treatment alternatives, including antidepressant medication, psychotherapies (e.g., CBT, IP, 
ACT, MBSR), ECT and TMS, recurrence rates of depression are still high (APA, 2013). To 
date, depression etiology is recognized as a complex interplay between biological 
predispositions and stressors (Pasquini et al., 2014; Southwick et al., 2005). Thus, all of the 
above mentioned theories trying to explain depression etiology might provide valid 
contributions, rather than just one having the “ultimate” answer.  
Modern psychiatry tries to distinguish between spectra of normal-abnormal and function-
dysfunction (Kendler et al., 2006; Stein, 2013; Stein et al., 2013), but has also been criticized 
for labeling normal variation as pathologic (Wakefield, 2013; Wakefield et al., 2013). For 
each successive edition of both ICD and DSM, the number of possible psychiatric diagnoses 
has increased. Although this growth of psychiatric categories, disorders and specifiers may 
help the diagnostic procedure, it may also add complexity. This is, for example, reflected in 
the number of pages: DSM-I consisted of 152 pages (1952, APA), whereas DSM-5 covers 
more than 800 pages. Moreover, the potential combinations of depressive symptoms alone 
are above 1000.  
Depressive symptoms have also been reported to be etiologically heterogeneous (Fried et al., 
2013). This “symptomatic heterogeneity” reflects that depression may be viewed as a 
spectrum disorder, or consist of a continuum, ranging from of a few depressive symptoms to 
a maximum of 10, where each of these individual symptoms may also vary in their 
intensities.  
DSM and ICD conceptualizations of depression have faced substantial criticism. For 
example, Holtzheimer and Mayberg stated: “it has lost its utility” (2011, p.1). They suggested 
to focus on the core symptoms of depression – depressed mood, anhedonia, worthlessness or 
guilt, poor concentration, and suicidal ideation – rather than including the highly variable 
somatic/vegetative symptoms (appetite, sleep, psychomotor activity, fatigue), which makes 
the definition of depression too broad. A new depression definition was proposed: “the 
inability to disengage from a negative mood state and the tendency to re-enter this state 
inappropriately” (p.1), and that the depressive state “reflects an etiologically non-specific 
response to stress/distress that includes a stereotypical set of emotional, cognitive-behavioral 
and somatic responses” (p.6). This conceptualization of depression argues that depression is 
a function of stress/distress, and that symptomatic heterogeneity in turn is a function of 
variation in stress responses. This may be especially true, as variability also exist in treatment 
response; some persons respond early in the treatment course, whereas others do so much 
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later (Keller et al., 2000; Trivedi et al., 2006); some persons do not respond to one 
pharmacological agent, but to another (Rush et al., 2006), other persons do not respond to 
pharmacological agents at all, but to psychotherapy (Thase et al., 2000), and vice versa; and 
other persons need a combination of pharmacological agents and psychotherapy in order to 
reach remission (Keller et al., 2000).  
Although the conceptualization of depression as a stress-induced disorder, or a subtype of 
depression, also face challenges, such as establishing cause and effect between stressful 
events and neurobiological alterations (Baune et al., 2009), there is also substantial evidence 
linking stress and depression (as described in section 5.4). Further support for stress playing a 
key role in the development in depression is that cortisol levels are higher in women than in 
men (Heuser et al., 1994; Laughlin & Barret-Connor, 2000), and depression prevalence is 
higher in women compared to men. In line with this reasoning, gender differences in 
depression prevalence emerge in puberty at the ages of 12-13, when sex hormones are 
increasing (Gotlib & Hammen, 2010), and animal studies have shown that ovarian steroids 
increase HPA-axis activity (Kirschbaum et al., 1996; Roy et al., 1999). Moreover, MBSR, a 
therapy that targets stress has shown good treatment efficacy in recurrent depression (for 
review, see Gotink et al., 2015).  
While both ICD-10 and DSM-5 criteria suffer from some shortcomings mentioned above, 
ICD-10 criteria was chosen for depression diagnosis in this thesis in an effort to 
accommodate some of these challenges. The reason for this was two-fold: (1) ICD-10 criteria 
offers distinctions between mild, moderate and severe depression, to reflect the view of a 
spectrum disorder; (2), depression in old age frequently presents with milder forms of 
depression, so that this population is underrepresented in the major depressive disorder 
prevalence of DSM-IV and DSM-5.  
 
5.6 LIMITATIONS 
As all studies in this thesis derived from the population-based SNAC-K study, there is some 
overlap of participants. Thus, the results from the four studies cannot be entirely viewed upon 
as independent from each other, but are rather interconnected. Furthermore, the Kungsholmen 
municipality, where all SNAC-K participants derive from, is not fully representative of the 
whole Swedish population, as this area is relatively affluent, and persons living here are 
generally healthier and have received more education compared to other parts of Sweden 
(Lagergren et al., 2004; Welmer et al., 2013).  
Not all SNAC-K participants (n=3363) underwent neuropsychological testing (refusals: 
n=515, 15.3% at baseline examinations). Furthermore, out of 180 persons with depression, 39 
persons (21.7%) refused cognitive testing. These persons were older than the depressed 
persons who did undergo neuropsychological testing, but they did not differ in rate of 
dementia diagnoses, MMSE performance, years of education, or depression severity.  
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Although the cognitive test battery used in SNAC-K is extensive and examines multiple 
cognitive domains, there was only one test measuring attention and executive functions, 
respectively. Multiple measurements of these cognitive domains could have further 
strengthened the results of Study III and IV, concerning the state-trait aspects of cognitive 
deficits in depression.  
Persons with psychiatric disorders are less likely to participate in research studies (Knudsen 
et al., 2010), which is reflected in the low baseline prevalence of persons with severe 
depression (0.25%, n=9). This makes it likely that many persons with severe depression were 
missed in the current studies. This, together with the relatively higher refusal rate for 
neuropsychological testing, is also reflected in rather small sample sizes of depressed 
participants, which in turn affected statistical power.  
To study depression in a large population-based study presents both opportunities and 
challenges. Designed for healthy and dementia-related aging, some depression-related 
information was lacking (e.g., data on neurotrophic factors, pro-inflammatory factors, and 
stress-related factors, such as repeated cortisol measurements). Although a relatively large 
subsample of SNAC-K participants underwent Magnetic Resonance Imaging (MRI; n=555), 
unfortunately the number of depressed participants who did MRI was small (n=16). Although 
clinically relevant information such as comorbidity of other psychiatric disorders, number of 
hospitalizations and cumulative inpatient days could be derived from the IPR, specific data 
on these variables were lacking, such as age of depression onset, number and duration of 
depressive episodes, as well as amount of time spent in remission. Also, information on 
treatments received during hospitalizations was lacking.  
 
5.7 IMPLICATIONS 
Cognitive deficits in depression are associated with longer episode durations and reduced 
remission rates (McCall & Dunn, 2003; Papakostas, 2014), higher rates of recurrence (Fossati 
et al., 2002; Majer et al., 2004), reduced coping abilities (Dunkin et al., 2000), poorer 
antidepressant treatment response (Koenig et al., 2014; Morimoto & Alexopoulos, 2013; 
Morimoto et al., 2015), greater overall disability (Koenig et al., 2014), reduced quality of life 
and high distress (Pandina et al., 2009; Shimuzu et al., 2013). Hence, cognitive deficits in 
depression are associated with a poor prognosis. This makes early detection of depression 
highly important as cognitive deficits are likely to exacerbate from mild through moderate to 
severe depression (Study I), as well as with recurrent episodes (Robinson & Sahakian, 2008; 
Stordal et al., 2004). 
Combined profiles of psychiatric history, cognitive performance and health behaviors may 
add important relevant information to individualized treatment. This is especially so, as about 
30-40% of depressed persons do not respond to antidepressant medication (Kuk et al., 2010; 
Trivedi et al., 2006), and as multiple factors have been shown to modulate patterns of 
cognitive deficits in old-age depression (Study I: depression severity; Study II: 
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disadvantageous alleles of memory-related genes; Study III: psychiatric history, cumulative 
inpatient days, prodromal dementia, comorbidity of psychiatric disorders and heart disease, 
physical inactivity; Study IV: benzodiazepine drug intake).  
This thesis provides evidence that cognitive deficits in depression are more state- than trait-
related (Study III and IV). Thus, cognitive deficits in depression seem more reversible than 
stable, but may take longer time to remit as compared to other depressive symptoms. The 
finding of reversibility suggests that cognitive deficits in depression should be regarded as 
treatment targets rather than stable vulnerabilities. Thus, measuring changes in cognitive 
peformance may provide an additional marker of treatment response. However, it needs to be 
taken into account that degree of reversibility is likely to diminish with age, when co-
occurring aging processes are taking place and the brain’s capacity for plasticity is declining 
(Coillard-Depres et al., 2011).  
Taken together, these implications are especially important as the older population is 
increasing (Christiansen et al., 2009), is less likely to report cardinal symptoms of depression 
such as sad mood (Brodaty et al., 2001; Gallo et al., 1997), and the depressive symptoms 
most likely add to other diseases and physical disabilities frequently occurring in old age 
(Alexopoulos, 2005; Beekman et al., 2002; Gottfries, 2001). 
 
5.8 CONCLUSIONS 
Depression is a heterogeneous disorder, and likewise the patterns of cognitive deficits in this 
condition seem to vary. Specific cognitive deficits in dementia-free unipolar old-age 
depression were shown to vary as a function of multiple factors, including: (1) depression 
severity; (2) disadvantageous alleles of memory-related genes; (3) psychiatric history and 
cumulative inpatient days; (4) prodromal dementia; (5) comorbidity of psychiatric disorders 
and heart disease; (6) physical inactivity, and; (7) benzodiazepine drug intake. This indicates 
that there is not one clear pattern of cognitive deficits in depression, but rather multiple 
patterns.  
Mild depression was more prevalent than moderate and severe depression in old age, and also 
underdetected, as reflected by the low proportions of antidepressant medication. This 
underscores the importance of early detection of depression, especially as untreated 
depression is likely to develop into moderate and severe depression (Alexopolous, 2003), and 
thus linked to exacerbated cognitive deficits.  
Cognitive deficits in dementia-free unipolar old-age depression seem to be largely reversible. 
As such, this finding suggests that cognitive deficits in depression should be regarded as 
potential treatment targets.  
Taken together, in order to provide the best treatment, and thus increase the likelihood of 
remission for depressed older persons, it would be valuable to combine profiles of psychiatric 
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history, cognitive performance, and health behaviors. Moreover, the assessment of combined 
profiles should preferably be repeated during different depression courses.  
 
5.9 FUTURE RESEARCH 
Ideally, a large-scale longitudinal study, following participants from young to old age 
investigating different depression courses, with repeated assessments of cognitive 
performance in combination with neuroimaging methods (MRI, fMRI, PET, ERP) biological 
(BDNF, cortisol, inflammatory markers, serotonin, norephinephrine, dopamine, glutamate, 
GABA), psychological (emotion regulation, inner-talk, coping strategies), and social (social 
activities, support, coping strategies) factors and health behaviors (exercise, nutrition, sleep) 
would be carried out. Such a design allows for comparisons of combined profiles of healthy 
persons prior to depression onset to the combined profiles during depression and in 
remission. This in turn can provide important knowledge on neurobiological markers of 
depression and its etiology, thereby guiding treatment options. Once a participant received a 
depression diagnosis, different treatment interventions may take place (antidepressant 
medication, CBT, MBSR, exercise and nutrition programs). When participants are 
nonresponsive to one treatment, they should be followed up and the treatment should be 
modified or augmented. This may give important knowledge on what makes one depressed 
person respond to one kind of treatment as opposed to another, and thus potentially further 
elucidate some of the heterogeneity in depression. Furthermore, important knowledge could 
also be obtained to design preventive interventions in healthy persons, in an attempt to 
increase resilience, and potentially reduce the incidence of depression in the future. For 
example, school children could be taught appropriate coping strategies, as well as emotion 
regulation.  
In the more immediate future, research should establish causal links between stress and 
depressive symptomatology, including cognitive deficits. Further insight into the degree of 
reversibility of cognitive deficits in depression is highly warranted. Multiple factors could be 
investigated here, including: (a) establishing factors that modulate reversibility; (b) do the 
modulating factors exert different degrees of influence in different stages of stress? (e.g., first 
onset vs. recurrent depression) and in different courses of depression (nondepressed-
depressed; depressed-remitted; remitted-depressed; depressed-depressed); and (c) what are 
the modulating factors’ influence on neurobiological changes (before depression onset, 
during depression and in remission for stress- and depression-related neural pathways and 
structures). 
Furthermore, deepened knowledge on the temporal aspect of reversibility of cognitive deficits 
is highly warranted, as little is known about this topic and cognitive deficits in depression are 
associated with poor prognosis. For example, how much more time is required in remission to 
reverse cognitive deficits in comparison to recovery from core symptoms of depression, and 
which factors regulate this process?  
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We still do not have sufficient knowledge about the heterogeneous depression disorder, 
reflected by high prevalence and recurrence rates, as well as by poor treatment responses. As 
such, there is no shortage of potential future studies that hopefully can elucidate the etiology 
of this disorder, its biological markers, and treatment responses. 
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